Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V St Georgiev

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Annals of the New York Academy of Sciences|June 23, 1993
Enzymes of the purine metabolism: inhibition and therapeutic potentialV St Georgiev
Annals of the New York Academy of Sciences|January 1, 1988
Fungal infections and the search for novel antifungal agents. Opening remarksV St Georgiev
Expert Opinion on Pharmacotherapy|May 5, 2001
Chemotherapy of enterobiasis (oxyuriasis)V St Georgiev
Medicinal Research Reviews|September 1, 1993
Opportunistic/nosocomial infections. Treatment and developmental therapeutics. ToxoplasmosisV St Georgiev
Journal of Pharmaceutical Sciences|February 1, 1974
CamptothecinM Shamma, V St Georgiev
Annals of the New York Academy of Sciences|June 23, 1993
Cytokines and their role as growth factors and in regulation of immune responsesV St Georgiev, J F Albright
Biochemical Pharmacology|April 15, 1979
Dihydro- and tetrahydroisoquinolines as inhibitors of cyclic nucleotide phosphodiesterases from dog heart. Structure-activity relationshipsR G Van Inwegen, P Salaman, V St Georgiev, et al.
Annals of the New York Academy of Sciences|January 1, 1988
In vitro activity of novel 5-(phenyl or phenoxyalkyl)-3-(2-thienyl)-3-(1H-imidazol-1-ylmethyl)-2- methylisoxazolidinesG B Mullen, J T Mitchell, S D Allen, et al.
Journal of Medicinal Chemistry|April 1, 1979
Drug-induced modifications of the immune response. 1. Substituted 1-phenylisoquinolinesV St Georgiev, R P Carlson, R G Van Inwegen, et al.
Journal of Pharmaceutical Sciences|December 1, 1988
5-( [aryl or aryloxy (or thio)]methyl)-3-(1H-imidazol-1-ylmethyl)-3- (2-thienyl)-2-methylisoxazolidine derivatives as novel antifungal agentsG B Mullen, J T Mitchell, S D Allen, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Annals of the New York Academy of Sciences|June 23, 1993
Enzymes of the purine metabolism: inhibition and therapeutic potentialV St Georgiev
Annals of the New York Academy of Sciences|January 1, 1988
Fungal infections and the search for novel antifungal agents. Opening remarksV St Georgiev
Expert Opinion on Pharmacotherapy|May 5, 2001
Chemotherapy of enterobiasis (oxyuriasis)V St Georgiev
Medicinal Research Reviews|September 1, 1993
Opportunistic/nosocomial infections. Treatment and developmental therapeutics. ToxoplasmosisV St Georgiev
Journal of Pharmaceutical Sciences|February 1, 1974
CamptothecinM Shamma, V St Georgiev
Annals of the New York Academy of Sciences|June 23, 1993
Cytokines and their role as growth factors and in regulation of immune responsesV St Georgiev, J F Albright
Biochemical Pharmacology|April 15, 1979
Dihydro- and tetrahydroisoquinolines as inhibitors of cyclic nucleotide phosphodiesterases from dog heart. Structure-activity relationshipsR G Van Inwegen, P Salaman, V St Georgiev, et al.
Annals of the New York Academy of Sciences|January 1, 1988
In vitro activity of novel 5-(phenyl or phenoxyalkyl)-3-(2-thienyl)-3-(1H-imidazol-1-ylmethyl)-2- methylisoxazolidinesG B Mullen, J T Mitchell, S D Allen, et al.
Journal of Medicinal Chemistry|April 1, 1979
Drug-induced modifications of the immune response. 1. Substituted 1-phenylisoquinolinesV St Georgiev, R P Carlson, R G Van Inwegen, et al.
Journal of Pharmaceutical Sciences|December 1, 1988
5-( [aryl or aryloxy (or thio)]methyl)-3-(1H-imidazol-1-ylmethyl)-3- (2-thienyl)-2-methylisoxazolidine derivatives as novel antifungal agentsG B Mullen, J T Mitchell, S D Allen, et al.
Pageof 4